Integrative Tumor Board: Recurrent Breast Cancer or New Primary?

Abstract

References

1. Bonnadonna G, Brusamolino E, Valagussa P. Combination chemotherapy as adjuvant treatment in operable breast cancer . N Engl J Med. 1976;294: 405-410 .

2. Peters WP, Rosner G, Vredenburgh E. Update of results of a prospective, randomized comparison of two doses of combination alkylator agents as consolidation after CAF in high-risk primary breast cancer involving ten or more axillary lymph nodes . Proc Am Soc Clin Oncol. 2001;20: 21a (abstract 81).

3. Early Breast Cancer Trialists Collaboration Group. Polychemotherapy for early breast cancer: overview of the randomized trial . Lancet. 1998;352: 930-942 .

4. Fisher B, Constantino J, Wickerman DC. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study . J Natl Cancer Inst. 1998;90: 1371 .

5. Fisher B, Droman J, Bryant J. Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor positive tumors . J Natl Cancer Inst. 1996;88: 1529-1534 .

6. Jaffer S, Goldfarb AB, Gold JE, Szpom A, Bleiweiss IJ. Contralateral axillary lymph node metastases as the first evidence of locally recurrent breast carcinoma . Cancer. 1995;75: 2875-2878 .

7. Bardou VJ, Arpino G, Elledge RM, Osborne CK, Clark GM. Progesterone receptor status significantly improves outcome prediction over estrogen receptor status alone for adjuvant endocrine therapy in two large breast cancer databases . J Clin Oncol. 2003;21: 1973-1979 .

8. Mokbel K. Recent advances in breast cancer: the 25th Annual San Antonio Breast Cancer Symposium . Curr Med Res Opin. 2003;19: 143-146 .

9. Goodwin PJ, Ennis M, Pritchard KI, et al. Fasting insulin and outcomes in early stage breast cancer: results of a prospective cohort study . J Clin Oncol. 2002;20: 42-51 .

10.

10. Pandini G, Vigneri R, Costantino A, et al. Insulin and insulin-like growth factor-1 (IGF-1) receptor overexpression in breast cancer leads to insulin/IGF-1 hybrid receptor overexpression: evidence for a second mechanism of IGF-1 signalling . Clin Cancer Res. 1995;5: 1935-1944 .

11.

11. Kliukiele J, Tynes T, Anderson A. Risk of breast cancer among Norwegian women with visual impairment . Br J Cancer. 2001;84: 347-349 .

12.

12. Poole C. The darkness at the end of the tunnel: summary and evaluation of an international symposium. On light, endocrine systems and cancer . Neuroendocrinol Lett. 2002;23 (Suppl 2): 71-78 .

13.

13. Schernhammer ES, Laden F, Speizer FE, et al. Rotating night shifts and risk of breast cancer in women participating in the Nurses Health Study . J Natl Cancer Inst. 2001;93: 1563-1568 .

14.

14. Schernhammer ES, Laden F, Speizer FE, et al. Night shift work and risk of colorectal cancer in the Nurses Health Study . J Natl Cancer Inst. 2003;95: 825-828 .